The effect of PPP2CA expression on the prognosis of patients with hepatocellular carcinoma and its molecular biological characteristics.

Background To investigate the role of the PPP2CA gene in the prognosis of patients with hepatocellular carcinoma (HCC) and its molecular biological characteristics. Methods We performed comparison of the expression of PPP2CA in HCC and non-HCC tissues of HCC patients who underwent surgery for the first time in the Tumor Hospital of Guangxi Medical University from July 2017 to July 2019, and retrospectively analyzed the relevant clinical data and prognosis. The GSE76427 data set and bioinformatics and public databases were used to compare the expression of PPP2CA between HCC and non-cancer tissues. Gene Ontology (GO) analysis was performed of PPP2CA and its differential genes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. A protein-protein interaction (PPI) network of PPP2CA and its differentially expressed genes (DEGs) was constructed from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database and visualized by Cytoscape software. Results The immunohistochemistry (IHC) of tissue sections confirmed that PPP2CA was highly expressed in most HCC tissues; the high expression of PPP2CA was significantly correlated with microvascular invasion (MVI) and portal vein tumor thrombi (P<0.05). Participants in the PPP2CA high expression group had worse overall survival (OS; P=0.04) and recurrence-free survival (RFS; P=0.019). The PPP2CA gene and 71 DEGs were mainly enriched in the nuclear division, organelle fission, nuclear chromosome separation, and chromatid separation process, and KEGG analysis revealed enrichment in drug metabolism-cytochrome metabolism of xenobiotics by P450 and cytochrome P450. Finally, through the PPI network, CCNA2, AURKB, TOP2A, NCAPG, MCM2, CDC20, CCMB2, AURKA, and MGST1 were identified as the top 9 highly connected hub genes. Conclusions The PPP2CA gene is highly expressed in HCC tissues. The high expression of PPP2CA is significantly associated with poor prognosis. Through the analysis of DEGs, GO and KEGG pathway analysis, it was found that PPP2CA may act on liver cancer through multiple targets and multiple pathways, and PPP2CA plays a promoting role in HCC.

[1]  J. Zhong,et al.  Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma , 2021, Journal of clinical and translational hepatology.

[2]  S. Lau,et al.  The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer , 2020, Bioscience reports.

[3]  G. Schneider,et al.  The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[4]  J. Ferlay,et al.  International trends in hepatocellular carcinoma incidence, 1978–2012 , 2020, International journal of cancer.

[5]  Vidhi M. Shah,et al.  Select Stabilization of a Tumor-Suppressive PP2A Heterotrimer. , 2020, Trends in pharmacological sciences.

[6]  N. Baddour,et al.  Predictors for hepatocellular carcinoma recurrence after microwave ablation , 2020, Clinical and experimental hepatology.

[7]  Xinli Zhan,et al.  KEGG-expressed genes and pathways in triple negative breast cancer , 2020, Medicine.

[8]  Y. Zhang,et al.  The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis , 2020, BioMed research international.

[9]  J. Kong,et al.  Okadaic acid promotes epithelial‐mesenchymal transition of hepatocellular carcinoma cells by inhibiting protein phosphatase 2A , 2020, Journal of cellular biochemistry.

[10]  Jin Ma,et al.  Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis , 2019, Oncology reports.

[11]  U. Teixeira,et al.  Treatment strategies for locally advanced hepatocellular carcinoma. , 2019, Translational gastroenterology and hepatology.

[12]  R. Honkanen,et al.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C , 2019, Molecular Cancer Therapeutics.

[13]  S. Pervaiz,et al.  Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression , 2019, Redox biology.

[14]  Z. YuFeng,et al.  Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study. , 2018, International journal of surgery.

[15]  Seung Hoon Jeong,et al.  PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart , 2018, Experimental & Molecular Medicine.

[16]  L. Kong,et al.  Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis , 2018, OncoTargets and therapy.

[17]  J. Westermarck,et al.  Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer. , 2018, The international journal of biochemistry & cell biology.

[18]  Li Liu,et al.  Genetic variants in PPP2CA are associated with gastric cancer risk in a Chinese population , 2017, Scientific Reports.

[19]  J. Spiers,et al.  Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion , 2017, British journal of pharmacology.

[20]  Juan Xu,et al.  MTDH promotes glioma invasion through regulating miR-130b-ceRNAs , 2017, Oncotarget.

[21]  Shao-Juan Gong,et al.  Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma , 2016, Cancer biology & therapy.

[22]  C. Yuh,et al.  Ribose‐5‐phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling , 2015, International journal of cancer.

[23]  C. Shiau,et al.  Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A , 2014, Cell Death and Disease.

[24]  Thomas V. O'brien,et al.  Oncogene expression profiles in K6/ODC mouse skin and papillomas following a chronic exposure to monomethylarsonous acid , 2009, Journal of biochemical and molecular toxicology.

[25]  V. Janssens,et al.  Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit* , 2007, Journal of Biological Chemistry.

[26]  M. Nassal,et al.  Inhibition of Alpha Interferon Signaling by Hepatitis B Virus , 2006, Journal of Virology.

[27]  Michael T. Dill,et al.  Protein phosphatase 2 A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p 53 , 2013 .